Terms and covenants support execution of Five-Point Plan and transition year fiscal 2024Expected to provide sufficient liquidity to support fiscal 2024 plans as Company advances to positive cash generation from
Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading entrepreneur edtech and education group, announces today that it has entered into a loan agreement with its CEO, Roger James Hamilton, to
Edesa Biotech Inc (NASDAQ: EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
Revolving Line of Credit to Support Completion of Government-Funded ARDS StudyTORONTO, ON / ACCESSWIRE / October 12, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA) ("Edesa", or the "Company"), a clinical-stage
Bionano announced today that it has priced a financing to raise an aggregate of $80.0 million in a registered offering and concurrent private placement of senior secured convertible notes due 2025 and warrantsPreliminary
Canadian cannabis company Shiny Health & Wellness Corp. (TSXV: SNYB) announced a non-brokered private placement Wednesday consisting of gross proceeds of up to $500,000. Upon acceptance by the TSXV, it will close on the first tranche of the offering for gross proceeds of $225,000.
-8-K On October 3, 2023, General Motors Company (“GM”) entered into a new 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders named